Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) — Form SCHEDULE 13G: Ownership over 5% (passive)
Summary from the key facts
Alnylam Pharmaceuticals, Inc. filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Oct 30, 2026.
Key facts
- Document
- —
More ALNY filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 4
Filed Oct 6, 2026
- 144
Filed Oct 2, 2026
- 4
Filed Sep 22, 2026
- 10-Q
Filed Jul 30, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.